Journal of Neural Transmission

, Volume 116, Issue 8, pp 953–974 | Cite as

Common key-signals in learning and neurodegeneration: focus on excito-amino acids, β-amyloid peptides and α-synuclein

  • L. F. Agnati
  • G. Leo
  • S. Genedani
  • L. Piron
  • A. Rivera
  • D. Guidolin
  • K. Fuxe
Basic Neurosciences, Genetics and Immunology - Original Article

Abstract

In this paper a hypothesis that some special signals (“key-signals” excito-amino acids, β-amyloid peptides and α-synuclein) are not only involved in information handling by the neuronal circuits, but also trigger out substantial structural and/or functional changes in the Central Nervous System (CNS) is introduced. This forces the neuronal circuits to move from one stable state towards a new state, but in doing so these signals became potentially dangerous. Several mechanisms are put in action to protect neurons and glial cells from these potentially harmful signals. However, in agreement with the Red Queen Theory of Ageing (Agnati et al. in Acta Physiol Scand 145:301–309, 1992), it is proposed that during ageing these neuroprotective processes become less effective while, in the meantime, a shortage of brain plasticity occurs together with an increased need of plasticity for repairing the wear and tear of the CNS. The paper presents findings supporting the concept that such key-signals in instances such as ageing may favour neurodegenerative processes in an attempt of maximizing neuronal plasticity.

Keywords

Learning Neurodegeneration Excito-amino acids β-amyloid peptides α-synuclein Homocysteine 

References

  1. Abbott LF, Nelson SB (2000) Synaptic plasticity: taming the beast. Nat Neurosci 3(Suppl):1178–1183PubMedCrossRefGoogle Scholar
  2. Abraham WC, Bear MF (1996) Metaplasticity: the plasticity of synaptic plasticity. Trends Neurosci 19:126–130PubMedCrossRefGoogle Scholar
  3. Agnati LF, Fuxe K (1984) New concepts on the structure of the neuronal networks: the miniaturization and hierarchical organization of the central nervous system (Hypothesis). Biosci Rep 4(2):93–98PubMedCrossRefGoogle Scholar
  4. Agnati LF, Fuxe K, Zoli M, Rondanini C, Ogren SO (1982) New vistas on synaptic plasticity: the receptor mosaic hypothesis of the engram. Med Biol 60:183–190PubMedGoogle Scholar
  5. Agnati LF, Zoli M, Biagini G, Fuxe K (1992) Neuronal plasticity and ageing processes in the frame of the ‘Red Queen Theory’. Acta Physiol Scand 145:301–309PubMedCrossRefGoogle Scholar
  6. Agnati LF, Cortelli P, Pettersson R, Fuxe K (1995) The concept of trophic units in the central nervous system. Prog Neurobiol 46:561–574PubMedCrossRefGoogle Scholar
  7. Agnati LF, Santarossa L, Benfenati F, Ferri M, Morpurgo A, Apolloni B, Fuxe K (2002) Molecular basis of learning and memory: modelling based on receptor mosaics. In: Apolloni B, Kurfes F (eds) From synapses to rules. Kluwer/Plenum Publishers, New York, pp 165–196Google Scholar
  8. Agnati LF, Ferré S, Lluis C, Franco R, Fuxe K (2003a) Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons. Pharmacol Rev 55:509–550PubMedCrossRefGoogle Scholar
  9. Agnati LF, Franzen O, Ferré S, Leo G, Franco R, Fuxe K (2003b) Possibile role of intramembrane receptor-receptor interactions in memory and learning via formation of long-lived heteromeric complexes: focus on motor learning in the basal ganglia. J Neural Transm Suppl 65:1–28PubMedGoogle Scholar
  10. Agnati LF, Santarossa L, Genedani S, Canela EI, Leo G, Franco R, Woods A, Lluis C, Ferrè S, Fuxe K (2004a) On the nested hierarchical organization of CNS: basic characteristics of neuronal molecular networks. In: Erdi P, Esposito A, Marinaro M, Scarpetta S (eds) Computational neuroscience: cortical dynamycs, Lecture Notes in Computer Sciences. Springer, Heidelberg, pp 24–54Google Scholar
  11. Agnati LF, Ferrè S, Genedani S, Franzini C, Woods AS, Franco R, Yang S-N, Fuxe K (2004b) The neurobiological bases of consciousness the multiple mirror network hypothesis. Acc Naz Sci Lett Arti di Modena Sez. VIII, v. VII, fasc IGoogle Scholar
  12. Agnati LF, Genedani S, Rasio G, Galantucci M, Saltini S, Filaferro M, Franco R, Mora F, Ferré S, Fuxe K (2005a) Studies on homocysteine plasma levels in Alzheimer’s patients. Relevance for neurodegeneration. J Neural Transm 112:163–169PubMedCrossRefGoogle Scholar
  13. Agnati LF, Guidolin D, Genedani S, Ferré S, Bigiani A, Woods AS, Fuxe K (2005b) How proteins come together in the plasma membrane and function in macromolecular assemblies: Focus on receptor mosaics. J Mol Neurosci 26:133–154PubMedCrossRefGoogle Scholar
  14. Agnati LF, Ferré S, Genedani S, Leo G, Guidolin D, Filaferro M, Carriba P, Casadó V, Lluis C, Franco R, Woods AS, Fuxe K (2006a) Allosteric modulation of dopamine D2 receptors by homocysteine. J Proteome Res 5:3077–3083PubMedCrossRefGoogle Scholar
  15. Agnati LF, Genedani S, Carone C, Leo G, Fuxe K (2006b) The concept of protein mosaics: physiological role and relevance for prion disease. Curr Proteomics 3:171–179CrossRefGoogle Scholar
  16. Agnati LF, Guidolin D, Leo G, Genedani S, Arhem P, Forni A, Andreoli N, Fuxe K (2007a) Role of cooperativity in protein folding and protein mosaic assemblage relevance for protein conformational diseases. Curr Protein Pept Sci 8:460–470PubMedCrossRefGoogle Scholar
  17. Agnati LF, Genedani S, Leo G, Forni A, Woods AS, Filaferro M, Franco R, Fuxe K (2007b) Abeta peptides as one of the crucial volume transmission signals in the trophic units and their interactions with homocysteine. Physiological implications and relevance for Alzheimer’s disease. J Neural Transm 114:21–31PubMedCrossRefGoogle Scholar
  18. Agnati LF, Leo G, Genedani S, Andreoli N, Marcellino D, Woods A, Piron L, Guidolin D, Fuxe K (2007b) Structural plasticity in G-protein coupled receptors as demonstrated by the allosteric actions of homocysteine and computer-assisted analysis of disordered domains. Brain Res Rev. doi:10.1016/j.brainresrev.2007.10.00
  19. Agnati LF, Baldelli E, Andreoli N, Woods AS, Vellani V, Marcellino D, Guidolin D, Fuxe K (2008) On the key role played by altered protein conformation in Parkinson’s disease. J Neural Transm. doi:10.1007/s00702-008-0072-1
  20. Algaidi SA, Christie LA, Jenkinson AM, Whalley L, Riedel G, Platt B (2006) Long-term homocysteine exposure induces alterations in spatial learning, hippocampal signalling and synaptic plasticity. Exp Neurol 197:8–21PubMedCrossRefGoogle Scholar
  21. Amanoa A, Ujiharab H, Matsubayashia H, Sasaa M (1994) Corresponding Author Contact Information, Takeharu Yokotac, Yutaka Tamurac and Akinori AkaikecDopamine-induced protection of striatal neurons against kainate receptor-mediated glutamate cytotoxicity in vitro. Brain Res 655:61–69CrossRefGoogle Scholar
  22. Armstrong RA, Lantos PL, Cairns NJ (2008) What determines the molecular composition of abnormal protein aggregates in neurodegenerative disease? Neuropathology 28:351–365PubMedCrossRefGoogle Scholar
  23. Arvanitis DN, Ducatenzeiler A, Ou JN, Grodstein E, Andrews SD, Tendulkar SR, Ribeiro-da-Silva A, Szyf M, Cuello AC (2007) High intracellular concentrations of amyloid-beta block nuclear translocation of phosphorylated CREB. J Neurochem 103(1):216–228PubMedGoogle Scholar
  24. Atwood CS, Obrenovich ME, Liu T, Chan H, Perry G, Smith MA, Martins RN (2003) Amyloid-beta: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-beta. Brain Res Brain Res Rev 43:1–16PubMedCrossRefGoogle Scholar
  25. Austin RC, Sood SK, Dorward AM (1998) Homocysteine-dependent alterations in mitochondrial gene expression, function and structure. Homocysteine and H2O2 act synergistically to enhance mitochondrial damage. J Biol Chem 273:30808–30817PubMedCrossRefGoogle Scholar
  26. Baars BJ, Ramsy TZ, Laureys S (2003) Brain, conscious experience and the observing self. Trends Neurosci 26:671–675PubMedCrossRefGoogle Scholar
  27. Bandhyopadhyay U, Cuervo AM (2007) Chaperone-mediated autophagy in aging and neurodegeneration: lessons from alpha-synuclein. Exp Gerontol 42:120–128PubMedCrossRefGoogle Scholar
  28. Basu S, Nagy JA, Pal S, Vasile E, Eckelhoefer IA, Bliss VS, Manseau EJ, Dasgupta PS, Dvorak HF, Mukhopadhyay D (2001) The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor. Nat Med 7(5):569–574PubMedCrossRefGoogle Scholar
  29. Bazán-Peregrino M, Gutiérrez-Kobeh L, Morán J (2007) Role of brain-derived neurotrophic factor in the protective action of N-methyl-d-aspartate in the apoptotic death of cerebellar granule neurons induced by low potassium. J Neurosci Res 85:332–341PubMedCrossRefGoogle Scholar
  30. Beck H, Yaari Y (2008) Plasticity of intrinsic neuronal properties in CNS disorders. Nat Rev Neurosci 9:357–369PubMedCrossRefGoogle Scholar
  31. Bell JK, Botos I, Hall PR, Askins J, Shiloach J, Segal DM, Davies DR (2005) The molecular structure of the Toll-like receptor 3 ligand-binding domain. Proc Natl Acad Sci USA 102:10976–10980PubMedCrossRefGoogle Scholar
  32. Berretta N, Nisticò R, Bernardi G, Mercuri NB (2008) Synaptic plasticity in the basal ganglia: a similar code for physiological and pathological conditions. Prog Neurobiol 84(4):343–362PubMedCrossRefGoogle Scholar
  33. Bliss TV, Collingridge GL (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361(6407):31–39PubMedCrossRefGoogle Scholar
  34. Blitzer RD, Wong T, Giovannini MG, Pangalos MN, Robakis K, Landau EM (2000) Amyloid beta peptides activate the phosphoinositide signaling pathway in oocytes expressing rat brain RNA. Brain Res Mol Brain Res 76:115–120PubMedCrossRefGoogle Scholar
  35. Block ML, Zecca L, Hong J-S (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8:57–59PubMedCrossRefGoogle Scholar
  36. Boldyrev AA, Johnson P (2007) Homocysteine and its derivatives as possible modulators of neuronal and non-neuronal cell glutamate receptors in Alzheimer’s disease. J Alzheimers Dis 11(2):219–228PubMedGoogle Scholar
  37. Boscolo E, Folin M, Nico B, Grandi C, Mangieri D, Longo V, Scienza R, Zampieri P, Conconi MT, Parnigotto PP, Ribatti D (2007) Beta amyloid angiogenic activity in vitro and in vivo. Int J Mol Med 19(4):581–587PubMedGoogle Scholar
  38. Bozzi Y, Borrelli E (2006) Dopamine in neurotoxicity and neuroprotection: what do D2 receptors have to do with it? Trends Neurosci 29(3):167–174PubMedCrossRefGoogle Scholar
  39. Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, Zurdo J, Taddei N, Ramponi G, Dobson CM, Stefani M (2002) Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416:507–511PubMedCrossRefGoogle Scholar
  40. Burke SN, Barnes CA (2006) Neural plasticity in the ageing brain. Nat Rev Neurosci 7:30–40PubMedCrossRefGoogle Scholar
  41. Cabin DE, Shimazu K, Murphy D, Cole NB, Gottschalk W, McIlwain KL, Orrison B, Chen A, Ellis CE, Paylor R, Lu B, Nussbaum RL (2002) Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. J Neurosci 22(20):8797–8807PubMedGoogle Scholar
  42. Cajal S (1895) Algunas conjeturas sobre el mecanismo anatómico de la ideación, asociación y atención. Rev Med Cir Prácticas 19:497–508Google Scholar
  43. Caldeira MV, Melo CV, Pereira DB, Carvalho RF, Carvalho AL, Duarte CB (2007) BDNF regulates the expression and traffic of NMDA receptors in cultured hippocampal neurons. Mol Cell Neurosci 35:208–219PubMedCrossRefGoogle Scholar
  44. Cantara S, Donnini S, Morbidelli L, Giachetti A, Schulz R, Memo M, Ziche M (2004) Physiological levels of amyloid peptides stimulate the angiogenic response through FGF-2. FASEB J 18(15):1943–1945PubMedGoogle Scholar
  45. Cao LH, Yang XL (2008) Natriuretic peptides and their receptors in the central nervous system. Prog Neurobiol 84:234–248PubMedCrossRefGoogle Scholar
  46. Caughey B, Baron GS (2006) Prions and their partners in crime. Nature 443:803–810PubMedCrossRefGoogle Scholar
  47. Cepeda C, Colwell C, Itri N, Levine S (1998) Dopaminergic modulation of early signs of excitotoxicity in visualized rat neostriatal neurons. Eur J Neurosci 10:3491–3497PubMedCrossRefGoogle Scholar
  48. Chan SL, Fu W, Zhang P, Cheng A, Lee J, Kokame K, Mattson MP (2004) Herp stabilizes neuronal Ca2+ homeostasis and mitochondrial function during endoplasmic reticulum stress. J Biol Chem 279:28733–28743PubMedCrossRefGoogle Scholar
  49. Chandra S, Gallardo G, Fernández-Chacón R, Schlüter OM, Südhof TC (2005) Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell 123:383–396PubMedCrossRefGoogle Scholar
  50. Chen J, Rusnak M, Luedtke RR, Sidhu A (2004) D1 dopamine receptor mediates dopamine-induced cytotoxicity via the ERK signal cascade. J Biol Chem 279:39317–39330PubMedCrossRefGoogle Scholar
  51. Chern CL, Huang RF, Chen YH, Cheng JT, Liu TZ (2001) Folate deficiency-induced oxidative stress and apoptosis are mediated via homocysteine-dependent overproduction of hydrogen peroxide and enhanced activation of NF-kappaB in human Hep G2 cells. Biomed Pharmacother 55:434–442PubMedCrossRefGoogle Scholar
  52. Christofoletti G, Oliani MM, Gobbi S, Stella F, Bucken Gobbi LT, Renato Canineu P (2008) A controlled clinical trial on the effects of motor intervention on balance and cognition in institutionalized elderly patients with dementia. Clin Rehabil 22:618–626PubMedCrossRefGoogle Scholar
  53. Ciallella JR, Figueiredo H, Smith-Swintosky V, McGillis JP (1999) Thrombin induces surface and intracellular secretion of amyloid precursor protein from human endothelial cells. Thromb Haemost 81:630–637PubMedGoogle Scholar
  54. Cicerone MT (1997) De Senectude, Mondadori, MilanoGoogle Scholar
  55. Cingolani LA, Goda Y (2008) Actin in action: the interplay between the actin cytoskeleton and synaptic efficacy. Nat Rev Neurosci 9:344–356PubMedCrossRefGoogle Scholar
  56. Conchillo-Solé O, de Groot NS, Avilés FX, Vendrell J, Daura X, Ventura S (2007) AGGRESCAN: a server for the prediction and evaluation of “hot spots” of aggregation in polypeptides. BMC Bioinformatics 8:65PubMedCrossRefGoogle Scholar
  57. Conforti L, Adalbert R, Coleman MP (2007) Neuronal death: where does the end begin? Trends Neurosci 30:159–166PubMedCrossRefGoogle Scholar
  58. Cookson MR, van der Brug M (2008) Cell systems and the toxic mechanism(s) of alpha-synuclein. Exp Neurol 209:5–11PubMedCrossRefGoogle Scholar
  59. D’Antoni S, Berretta A, Bonaccorso CM, Bruno V, Aronica E, Nicoletti F, Catania MV. (2008) Metabotropic Glutamate Receptors in Glial Cells. Neurochem Res PMID: 1843871Google Scholar
  60. Davis S, Brotchie J, Davies I (2002) Protection of striatal neurons by joint blockade of D1 and D2 receptor subtypes in an in vitro model of cerebral hypoxia. Exp Neurol 176:229–236PubMedCrossRefGoogle Scholar
  61. Desai NS (2003) Homeostatic plasticity in the CNS: synaptic and intrinsic forms. J Physiol 97:391–402Google Scholar
  62. Díaz-Nido J, Wandosell F, Avila J (2002) Glycosaminoglycans and beta-amyloid, prion and tau peptides in neurodegenerative diseases. Peptides 23:1323–1332PubMedCrossRefGoogle Scholar
  63. Dicou E, Rangon CM, Guimiot F, Spedding M, Gressens P (2003) Positive allosteric modulators of AMPA receptors are neuroprotective against lesions induced by an NMDA agonist in neonatal mouse brain. Brain Res 970(1–2):221–225PubMedCrossRefGoogle Scholar
  64. Dobson CM (2003) Protein folding and misfolding. Nature 426:8848–8890CrossRefGoogle Scholar
  65. Doya K (2000) Complementary roles of basal ganglia and cerebellum in learning and motor control. Curr Opin Neurobiol 10:732–739PubMedCrossRefGoogle Scholar
  66. Dröge W, Schipper HM (2007) Oxidative stress and aberrant signaling in aging and cognitive decline. Aging Cell 6:361–370PubMedCrossRefGoogle Scholar
  67. Dunker AK, Brown CJ, Lawson JD, Iakoucheva LM, Obradović Z (2002) Intrinsic disorder and protein function. Biochemistry 41:6573–6582PubMedCrossRefGoogle Scholar
  68. Engelender S (2008) Ubiquitination of alpha-synuclein and autophagy in Parkinson’s disease. Autophagy 4(3):372–374PubMedGoogle Scholar
  69. Ertugrul DT, Gursoy A, Sahin M, Unal AD, Pamuk B, Berberoglu Z, Ayturk S, Tutuncu NB, Demirag NG (2008) Evaluation of brain natriuretic peptide levels in hyperthyroidism and hypothyroidism. J Natl Med Assoc 100:401–405PubMedGoogle Scholar
  70. Esteban JA (2004) Living with the enemy: a physiological role for the beta-amyloid peptide. Trends Neurosci 27:1–3PubMedCrossRefGoogle Scholar
  71. Farfara D, Lifshitz V, Frenkel D (2008) Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer’s disease. J Cell Mol Med 12(3):762–780PubMedCrossRefGoogle Scholar
  72. Fellin T, D’Ascenzo M, Philip G (2007) Haydon astrocytes control neuronal excitability in the nucleus accumbens. Sci World J 7S(2):89–97Google Scholar
  73. Fiala JC (2007) Mechanisms of amyloid plaque pathogenesis. Acta Neuropathol 114(6):551–571PubMedCrossRefGoogle Scholar
  74. Fiorentini C, Gardoni F, Spano P, Di Luca M, Missale C (2003) Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-d-aspartate receptors. J Biol Chem 278:20196–20202PubMedCrossRefGoogle Scholar
  75. Fortin DL, Nemani VM, Voglmaier SM, Anthony MD, Ryan TA, Edwards RH (2005) Neural activity controls the synaptic accumulation of alpha-synuclein. J Neurosi 25:10913–10921Google Scholar
  76. Frandsen A, Schousboe A (2003) AMPA receptor-mediated neurotoxicity: role of Ca2+ and desensitization. Neurochem Res 28(10):1495–1499PubMedCrossRefGoogle Scholar
  77. Fratiglioni L, Wang HX (2007) Brain reserve hypothesis in dementia. J Alzheimers Dis 12:11–22PubMedGoogle Scholar
  78. Fuxe K, Agnati LF (1992) Neurotrophic factors and central dopamine neurons. Neurosci Facts 3:81–84Google Scholar
  79. Fuxe KG, Tarakanov AO, Goncharova LB, Agnati LF (2008a) A new road to neuroinflammation in Parkinson’s disease? Brain Res Rev doi:10.1016/j.brainresrev.2008.04.003
  80. Fuxe K, Marcellino D, Antonelli T, Mudó G, Manger P, Genedani S, Ferraro L, Belluardo N, Manganelli S, Agnati LF (2008b) The nigro-striatal DA neurons and mechanisms of their degeneration in Parkinson’s disease. In: Ribak C et al (eds) From development to degeneration and regeneration of the nervous system, Oxford University Press, pp 119–141Google Scholar
  81. Gay NJ, Gangloff M, Weber ANR (2006) Toll-like receptors as molecular switches. Nat Rev Immunol 6:693–698PubMedCrossRefGoogle Scholar
  82. Gazzaniga MS (2000) Neuroscience. Regional differences in cortical organization. Science 289:1887–1888PubMedCrossRefGoogle Scholar
  83. Genedani S, Rasio G, Cortelli P, Antonelli F, Guidolin D, Galantucci M, Fuxe K, Agnati LF (2004) Studies on homocysteine and dehydroepiandrosterone sulphate plasma levels in Alzheimer’s disease patients and in Parkinson’s disease patients. Neurotox Res 6:327–332PubMedGoogle Scholar
  84. Gibbs ME, Hutchinson D, Hertz L (2008) Astrocytic involvement in learning and memory consolidation. Neurosci Biobehav Rev 32(5):927–944PubMedCrossRefGoogle Scholar
  85. Giorgio M, Trinei M, Migliaccio E, Pelicci PG (2007) Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals? Nat Rev Mol Cell Biol 8:722–728PubMedCrossRefGoogle Scholar
  86. Gitler AD, Shorter J (2007) Prime time for alpha-synucle. J Neurosci 27(10):2433–2434PubMedCrossRefGoogle Scholar
  87. Gong Y, Chang L, Viola KL, Lacor PN, Lambert MP, Finch CE, Krafft GA, Klein WL (2003) Alzheimer’s disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc Natl Acad Sci USA 100:10417–10422PubMedCrossRefGoogle Scholar
  88. Good T, Smith D, Murphy R (1996) β-Amyloid peptide blocks the fast-inactivating K+ current in rat hippocampal neurons. Biophys J 70:296–304PubMedCrossRefGoogle Scholar
  89. Graybiel AM, Canales JJ, Capper-Loup C (2000) Levodopa-induced dyskinesias and dopamine-dependent stereotypies: a new hypothesis. Trends Neurosci 23(10 Suppl):S71–S77PubMedCrossRefGoogle Scholar
  90. Greger IH, Ziff EB, Penn AC (2007) Molecular determinants of AMPA receptor subunit assembly. Trends Neurosci 30:407–416PubMedCrossRefGoogle Scholar
  91. Grosshans DR, Clayton DA, Coultrap SJ, Browning MD (2002) LTP leads to rapid surface expression of NMDA but not AMPA receptors in adult rat CA1. Nat Neurosci 5(1):27–33PubMedCrossRefGoogle Scholar
  92. Gsponer J, Vendruscolo M (2006) Theoretical approaches to protein aggregation. Protein Pept Lett 13:287–293PubMedCrossRefGoogle Scholar
  93. Guidolin D, Fuxe K, Neri G, Nussdorfer GG, Agnati LF (2007) On the role of receptor-receptor interactions and volume transmission in learning and memory. Brain Res Rev 55:119–133PubMedCrossRefGoogle Scholar
  94. Hardingham GE, Bading H (2003) The yin and yang of NMDA receptor signalling. Trends Neurosci 26:81–89PubMedCrossRefGoogle Scholar
  95. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297(5580):353–356Google Scholar
  96. Heidmann T, Changeux JP (1986) Characterization of the transient agonist-triggered state of the acetylcholine receptor rapidly labeled by the noncompetitive blocker [3H]chlorpromazine: additional evidence for the open channel conformation. Biochemistry 25:6109–6113PubMedCrossRefGoogle Scholar
  97. Ho PI, Ashline D, Dhitavat S, Ortiz D, Collins SC, Shea TB, Rogers E (2003) Folate deprivation induces neurodegeneration: roles of oxidative stress and increased homocysteine. Neurobiol Dis 14:32–42PubMedCrossRefGoogle Scholar
  98. Hock C, Maddalena A, Raschig A, Muller-Spahn F, Eschweiler G, Hager K, Heuser I, Hampel H, Muller-Thomsen T, Oertel W, Wienrich M, Signorell A, Gonzalez-Agosti C, Nitsch RM (2000) Treatment with the selective muscarinic agonist talsaclidine decreases cerebrospinal fluid levels of total amyloid beta-peptide in patients with Alzheimer’s disease. Ann N Y Acad Sci 920:285–291PubMedGoogle Scholar
  99. Hofer SM, Berg S, Era P (2003) Evaluating the interdependence of aging-related changes in visual and auditory acuity, balance, and cognitive functioning. Psychol Aging 18(2):285–305PubMedCrossRefGoogle Scholar
  100. Huang YY, Colino A, Selig DK, Malenka RC (1992) The influence of prior synaptic activity on the induction of long-term potentiation. Science 255:730–733PubMedCrossRefGoogle Scholar
  101. Huber G, Bailly Y, Martin JR, Mariani J, Brugg B (1997) Synaptic β-amyloid precursor proteins increase with learning capacity in rats. Neuroscience 80:313–320PubMedCrossRefGoogle Scholar
  102. Isacson O, Lin I (2000) Cholinergic modulation of amyloid processing and dementia in animal models of Alzheimer’s disease. Ann N Y Acad Sci 920:309–314PubMedGoogle Scholar
  103. Isobe C, Murata T, Sato C, Terayama Y (2005) Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer’s disease and Parkinson’s disease. Life Sci 77:1836–1843PubMedCrossRefGoogle Scholar
  104. Jakubowski H (2004) Molecular basis of homocysteine toxicity in humans. Cell Mol Life Sci 61:470–487PubMedCrossRefGoogle Scholar
  105. Kagan BL, Azimov R, Azimova R (2004) Amyloid peptide channels. J Membr Biol 202:1–10PubMedCrossRefGoogle Scholar
  106. Kamenetz FR, Tomita T, Borchelt DR, Sisodia SS, Iwatsubo T, Malinow R (2000) Activity dependent secretion of β-amyloid: roles of β-amyloid in synaptic transmission. Soc Neurosci Abstr 26:491Google Scholar
  107. Kamenetz F, Tomita T, Hsieh H, Seabrook G, Borchelt D, Iwatsubo T, Sisodia S, Malinow R (2003) APP processing and synaptic function. Neuron 37(6):925–937PubMedCrossRefGoogle Scholar
  108. Kandel ER (2000) In: Kandel ER, Schwartz JH, Jessell TM (eds) Principles of neural scienceGoogle Scholar
  109. Kelly JW, Balch WE (2003) Amyloid as a natural product. J Cell Biol 161:461–462PubMedCrossRefGoogle Scholar
  110. Kim SJ, Linden DJ (2007) Ubiquitous plasticity and memory storage. Neuron 56:582–592PubMedCrossRefGoogle Scholar
  111. Kinor N, Geffen R, Golomb E, Zinman T, Yadid G (2001) Dopamine increases glial cell line-derived neurotrophic factor in human fetal astrocytes. Glia 33:143–150PubMedCrossRefGoogle Scholar
  112. Kishida KT, Pao M, Holland SM, Klann E (2005) NADPH oxidase is required for NMDA receptor-dependent activation of ERK in hippocampal area CA. J Neurochem 94:299–306PubMedCrossRefGoogle Scholar
  113. Kitamura Y, Kakimura Y, Taniguchi T (2002) Antiparkinsonian drugs and their neuroprotective effects. Biol Pharm Bull 25:284–290PubMedCrossRefGoogle Scholar
  114. Knobloch M, Mansuy IM (2008) Dendritic spine loss and synaptic alterations in Alzheimer’s disease. Mol Neurobiol 37(1):73–82PubMedCrossRefGoogle Scholar
  115. Koudinov AR, Berezov TT (2004) Alzheimer’s amyloid-beta (A beta) is an essential synaptic protein, not neurotoxic junk. Acta Neurobiol Exp (Wars) 64(1):71–79Google Scholar
  116. Kourie JI, Culverson AL, Farrelly PV, Henry CL, Laohachai KN (2002) Heterogeneous amyloid-formed ion channels as a common cytotoxic mechanism: implications for therapeutic strategies against amyloidosis. Cell Biochem Biophys 36:191–207PubMedCrossRefGoogle Scholar
  117. Kovacs GG, Budka H (2008) Prion diseases: from protein to cell pathology. Am J Pathol 172:555–565PubMedCrossRefGoogle Scholar
  118. Kullmann DM, Lamsa KP (2007) Long-term synaptic plasticity in hippocampal interneurons. Nat Rev Neurosci 8(9):687–699PubMedCrossRefGoogle Scholar
  119. Lacor PN, Buniel MC, Chang L, Fernandez SJ, Gong Y, Viola KL, Lambert MP, Velasco PT, Bigio EH, Finch CE, Krafft GA, Klein WL (2004) Synaptic targeting by Alzheimer’s-related amyloid oligomers. J Neurosci 24:10191–10200PubMedCrossRefGoogle Scholar
  120. Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M, Viola KL, Klein WL (2007) Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer’s disease. J Neurosci 27(4):796–807PubMedCrossRefGoogle Scholar
  121. LaFerla FM, Green KN, Oddo S (2007) Intracellular amyloid-beta in Alzheimer’s disease. Nat Rev Neurosci 8:499–509PubMedCrossRefGoogle Scholar
  122. Lal R, Lin H, Quist AP (2007) Amyloid beta ion channel: 3D structure and relevance to amyloid channel paradigm. Biochim Biophys Acta 1768:1966–1975PubMedCrossRefGoogle Scholar
  123. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL (1998) Diffusible, nonfibrillar ligands derived from Abeta1–42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95:6448–6453PubMedCrossRefGoogle Scholar
  124. Lau CG, Zukin RS (2007) NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci 8(6):413–426PubMedCrossRefGoogle Scholar
  125. Lee SJ (2008) Origins and effects of extracellular α-synuclein: implications in Parkinson’s disease. J Mol Neurosci 34:17–22PubMedCrossRefGoogle Scholar
  126. Lee FJ, Liu F, Pristupa ZB, Niznik HB (2001) Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis. FASEB J 15:916–926PubMedCrossRefGoogle Scholar
  127. Lee FJ, Xue S, Pei L, Vukusic B, Chéry N, Wang Y, Wang YT, Niznik HB, Yu XM, Liu F (2002) Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor. Cell 111:219–230PubMedCrossRefGoogle Scholar
  128. Leng Y, Chuang DM (2006) Endogenous alpha-synuclein is induced by valproic acid through histone desacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity. J Neurosci 26:7502–7512PubMedCrossRefGoogle Scholar
  129. Leo G, Genedani S, Filaferro M, Carone C, Andreoli N, Astancolle S, Davalli P, Fuxe K, Agnati LF (2007) Hyper-homocysteinemia alters amyloid peptide-clusterin interactions and neuroglial network morphology and function in the caudate after intrastriatal injection of amyloid peptides. Curr Alzheimer Res 4(3):305–313PubMedCrossRefGoogle Scholar
  130. Linding R, Jensen LJ, Diella F, Bork P, Gibson TJ, Russell RB (2003) Protein disorder prediction: implications for structural proteomics. Structure 11:1453–1459PubMedCrossRefGoogle Scholar
  131. Linding R, Schymkowitz J, Rousseau F, Diella F, Serrano L (2004) A comparative study of the relationship between protein structure and β-aggregation in globular and intrinsically disordered proteins. J Mol Biol 342:345–353PubMedCrossRefGoogle Scholar
  132. Lipton SA, Kim WK, Choi YB, Kumar S, D’Emilia DM, Rayudu PV, Arnelle DR, Stamler JS (1997) Neurotoxicity associated with dual actions of homocysteine at the N-methyl-d-aspartate receptor. Proc Natl Acad Sci U S A 94:5923–5928PubMedCrossRefGoogle Scholar
  133. Liu S, Fa M, Ninan I, Trinchese F, Dauer W, Arancio O (2007) Alpha-synuclein involvement in hippocampal synaptic plasticity: role of NO, cGMP, cGK and CaMKII. Eur J Neurosci 25(12):3583–3596PubMedCrossRefGoogle Scholar
  134. Mackowiak M, O’Neill MJ, Hicks CA, Bleakman D, Skolnick P (2002) An AMPA receptor potentiator modulates hippocampal expression of BDNF: an in vivo study. Neuropharmacology 43(1):1–10PubMedCrossRefGoogle Scholar
  135. Mahncke HW, Bronstone A, Merzenich MM (2006) Brain plasticity and functional losses in the aged: scientific bases for a novel intervention. Prog Brain Res 157:81–109PubMedCrossRefGoogle Scholar
  136. Martignoni E, Tassorelli C, Nappi G, Zangaglia R, Pacchetti C, Blandini F (2007) Homocysteine and Parkinson’s disease: a dangerous liaison? J Neurol Sci 257:31–37PubMedCrossRefGoogle Scholar
  137. Martin SJ, Grimwood PD, Morris RG (2000) Synaptic plasticity and memory: an evaluation of the hypothesis. Annu Rev Neurosci 23:649–711PubMedCrossRefGoogle Scholar
  138. Martinez-Vicente M, Talloczy Z, Kaushik S, Massey AC, Mazzulli J, Mosharov EV, Hodara R, Fredenburg R, Wu DC, Follenzi A, Dauer W, Przedborski S, Ischiropoulos H, Lansbury PT, Sulzer D, Cuervo AM (2008) Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy. J Clin Invest 118:777–788PubMedGoogle Scholar
  139. Mastroeni D, Grover A, Leonard B, Joyce JN, Coleman PD, Kozik B, Bellinger DL, Rogers J (2008) Microglial responses to dopamine in a cell culture model of Parkinson’s disease. Neurobiol Aging PMID: 18325635Google Scholar
  140. Matsushima N, Tanaka T, Enkhbayar P, Mikami T, Taga M, Yamada K, Kuroki Y (2007) Comparative sequence analysis of leucine-rich repeats (LRRs) within vertebrate toll-like receptors. BMC Genomics 8:124–145PubMedCrossRefGoogle Scholar
  141. Mattson MP, Chan SL (2003) Neuronal and glial calcium signaling in Alzheimer’s disease. Cell Calcium 34:385–397PubMedCrossRefGoogle Scholar
  142. Mattson MP, Magnus T (2006) Ageing and neuronal vulnerability. Nat Rev Neurosci 7:278–794PubMedCrossRefGoogle Scholar
  143. McCray BA, Taylor JP (2008) The role of autophagy in age-related neurodegeneration. Neurosignals 16(1):75–84PubMedCrossRefGoogle Scholar
  144. Milgram NW, Head E, Muggenburg B, Holowachuk D, Murphey H, Estrada J, Ikeda-Douglas CJ, Zicker SC, Cotman CW (2002) Landmark discrimination learning in the dog: effects of age, an antioxidant fortified food, and cognitive strategy. Neurosci Biobehav Rev 26:679–695PubMedCrossRefGoogle Scholar
  145. Missale C, Fiorentini C, Busi C, Collo G, Spano PF (2006) The NMDA/D1 receptor complex as a new target in drug development. Curr Top Med Chem 6:801–808PubMedCrossRefGoogle Scholar
  146. Mitchell J, Cooper A, Griffiths M, Cooper A (2002) Acute administration of haloperidol induces apoptosis of neurones in the striatum and substantia nigra in the rat. Neuroscience 109:89–99PubMedCrossRefGoogle Scholar
  147. Monti B, Polazzi E, Batti L, Crochemore C, Virgili M, Contestabile A (2007) Alpha-synuclein protects cerebellar granule neurons against 6-hydroxydopamine-induced death. J Neurochem 103:518–530PubMedCrossRefGoogle Scholar
  148. Mucke L, Masliah E, Yu GQ, Mallory M, Rockenstein EM, Tatsuno G, Hu K, Kholodenko D, Johnson-Wood K, McConlogue L (2000) High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci 20(11):4050–4058PubMedGoogle Scholar
  149. Ngandu T, von Strauss E, Helkala EL, Winblad B, Nissinen A, Tuomilehto J, Soininen H, Kivipelto M (2007) Education and dementia: what lies behind the association? Neurology 2007 69:1442–1450CrossRefGoogle Scholar
  150. Nicoll RA, Malenka RC (1999) Expression mechanisms underlying NMDA receptor-dependent long-term potentiation. Ann N Y Acad Sci 868:515–825PubMedCrossRefGoogle Scholar
  151. Nisticò R, Piccirilli S, Cucchiaroni ML, Armogida M, Guatteo E, Giampà C, Fusco FR, Bernardi G, Nisticò G, Mercuri NB (2008) Neuroprotective effect of hydrogen peroxide on an in vitro model of brain ischaemia. Br J Pharmacol 153:1022–1029PubMedCrossRefGoogle Scholar
  152. Norris EH, Giasson BI, Lee VM (2004) Alpha-synuclein: normal function and role in neurodegenerative diseases. Curr Top Dev Biol 60:17–54PubMedCrossRefGoogle Scholar
  153. O’Neill MJ, Hicks CA, Ward MA, Cardwell GP, Reymann JM, Allain H, Bentué-Ferrer D (1998) Dopamine D2 receptor agonists protect against ischaemia-induced hippocampal neurodegeneration in global cerebral ischaemia. Eur J Pharmacol 352:37–46PubMedCrossRefGoogle Scholar
  154. Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L, Berry R, Vassar R (2006) Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer’s disease mutations: potential factors in amyloid plaque formation. J Neurosci 26(40):10129–10140PubMedCrossRefGoogle Scholar
  155. Obeid R, Herrmann W (2006) Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett 580:2994–3005PubMedCrossRefGoogle Scholar
  156. Ong LL, Lim AP, Er CP, Kuznetsov SA, Yu H (2000) Kinectin-kinesin binding domains and their effects on organelle motility. J Biol Chem 275:32854–32860PubMedCrossRefGoogle Scholar
  157. Ordonez-Llanos J, Collinson PO, Christenson RH (2008) Amino-terminal pro-B-type natriuretic peptide: analytic considerations. Am J Cardiol 101:9–15PubMedCrossRefGoogle Scholar
  158. Oresnik M (2008) The influence of cognitive rehabilitation on cognitive competence in patients with Alzheimer’s disease. Psychiatr Danub 20:174–178PubMedGoogle Scholar
  159. OrsquoNeill MJ, Murray TK, Whalley K, Ward MA, Hicks CA, Woodhouse S, Osborne DJ, Skolnick P (2004) Neurotrophic actions of the novel AMPA receptor potentiator, LY404187, in rodent models of Parkinsonrsquos disease. Eur J Pharmacol 486(2):163–174CrossRefGoogle Scholar
  160. Otani S, Daniel H, Roisin MP, Crepel F (2003) Dopaminergic modulation of long-term synaptic plasticity in rat prefrontal neurons. Cereb Cortex 13:1251–1256PubMedCrossRefGoogle Scholar
  161. Parameshwaran K, Dhanasekaran M, Suppiramaniam V (2007) Amyloid beta peptides and glutamatergic synaptic dysregulation. Exp Neurol 210(1):7–13PubMedCrossRefGoogle Scholar
  162. Pawar AP, Dubay KF, Zurdo J, Chiti F, Vendruscolo M, Dobson CM (2005) Prediction of “Aggregation-prone” and “Aggregation-susceptible” regions in proteins associated with neurodegenerative diseases. J Mol Biol 350:379–392PubMedCrossRefGoogle Scholar
  163. Pearson HA, Peers C (2006) Physiological roles for amyloid beta peptides. J Physiol 575(Pt 1):5–10PubMedCrossRefGoogle Scholar
  164. Perła-Kaján J, Twardowski T, Jakubowski H (2007) Mechanisms of homocysteine toxicity in humans. Amino Acids 32:561–572PubMedCrossRefGoogle Scholar
  165. Plant LD, Boyle JP, Smith IF, Peers C, Pearson HA (2003) The production of amyloid beta peptide is a critical requirement for the viability of central neurons. J Neurosci 23:5531–5535PubMedGoogle Scholar
  166. Quilty MC, King AE, Gai WP, Pountney DL, West AK, Vickers JC, Dickson TC (2006) Alpha-synuclein is upregulated in neurones in response to chronic oxidative stress and is associated with neuroprotection. Exp Neurol 199:249–256PubMedCrossRefGoogle Scholar
  167. Radivojac P, Obradović Z, Brown CJ, Dunker AK (2003) Prediction of boundaries between intrinsically ordered and disordered protein regions. Pac Symp Biocomput 8:216–227Google Scholar
  168. Richards M, Deary IJ (2005) A life course approach to cognitive reserve: a model for cognitive aging and development? Ann Neurol 58:617–622PubMedCrossRefGoogle Scholar
  169. Rochet JC, Outeiro TF, Conway KA, Ding TT, Volles MJ, Lashuel HA, Bieganski RM, Lindquist SL, Lansbury PT (2004) Interactions among alpha-synuclein, dopamine, and biomembranes: some clues for understanding neurodegeneration in Parkinson’s disease. J Mol Neurosci 23:23–34PubMedCrossRefGoogle Scholar
  170. Rodríguez-Alonso J, Montañez R, Rodríguez-Caso L, Medina MA (2008) Homocysteine is a potent modulator of plasma membrane electron transport systems. J Bioenerg Biomembr 40:45–51PubMedCrossRefGoogle Scholar
  171. Roe CM, Xiong C, Miller JP, Morris JC (2007) Education and Alzheimer disease without dementia: support for the cognitive reserve hypothesis. Neurology 68:223–228PubMedCrossRefGoogle Scholar
  172. Romero P, Obradovic Z, Dunker AK (1997) Sequence data analysis for long disordered regions prediction in the calcineurin family. Genome Inform 8:110–124Google Scholar
  173. Ross CA, Poirier MA (2004) Protein aggregation and neurodegenerative disease. Nat Med 10:S10–S17PubMedCrossRefGoogle Scholar
  174. Rothstein JD, Brem H (2001) Excitotoxic destruction facilitates brain tumor growth. Nat Med 7:994–995PubMedCrossRefGoogle Scholar
  175. Sabo SL, Ikin AF, Buxbaum JD, Greengard P (2003) The amyloid precursor protein and its regulatory protein, FE65, in growth cones and synapses in vitro and in vivo. J Neurosci 23(13):5407–5415PubMedGoogle Scholar
  176. Sánchez de Groot N, Pallarés I, Avilés FX, Vendrell J, Ventura S (2005) Prediction of hot spots of aggregation in disease-linked polypeptides. BMC Struct Biol 5:18PubMedCrossRefGoogle Scholar
  177. Sarkar C, Chakroborty D, Mitra RB, Banerjee S, Dasgupta PS, Basu S (2004) Dopamine in vivo inhibits VEGF-induced phosphorylation of VEGFR–2, MAPK, and focal adhesion kinase in endothelial cells. Am J Physiol Heart Circ Physiol 287(4):H1554–H1560PubMedCrossRefGoogle Scholar
  178. Schapira AH (2002) Neuroprotection and dopamine agonists. Neurology 58:S9–S18PubMedGoogle Scholar
  179. Schauwecker M, Steward O (1997) Genetic determinants of susceptibility to cytotoxic cell death: implications for gene targeting approaches. Proc Natl Acad Sci USA 94:4103–4108PubMedCrossRefGoogle Scholar
  180. Schindowski K, Belarbi K, Buée L (2008) Neurotrophic factors in Alzheimer’s disease: role of axonal transport. Genes Brain Behav Suppl 1:43–56CrossRefGoogle Scholar
  181. Schotanus SM, Chergui K (2008) Dopamine D1 receptors and group I metabotropic glutamate receptors contribute to the induction of long-term potentiation in the nucleus accumbens. Neuropharmacology 54:837–844PubMedCrossRefGoogle Scholar
  182. Schultz W, Tremblay L, Hollerman JR (1998) Reward prediction in primate basal ganglia and frontal cortex. Neuropharmacology 37:421–429PubMedCrossRefGoogle Scholar
  183. Selig DK, Hjelmstad GO, Herron C, Nicoll RA, Malenka RC (1995) Independent mechanisms for long-term depression of AMPA and NMDA responses. Neuron 15(2):417–426PubMedCrossRefGoogle Scholar
  184. Serot JM, Barbé F, Arning E, Bottiglieri T, Franck P, Montagne P, Nicolas JP (2005) Homocysteine and methylmalonic acid concentrations in cerebrospinal fluid: relation with age and Alzheimer’s disease. J Neurol Neurosurg Psychiatry 76:1585–1587PubMedCrossRefGoogle Scholar
  185. Seshadri S (2006) Elevated plasma homocysteine levels: risk factor or risk marker for the development of dementia and Alzheimer’s disease? J Alzheimers Dis 9:393–398PubMedGoogle Scholar
  186. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D’Agostino RB, Wilson PW, Wolf PA (2002) Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Engl J Med 346:476–483PubMedCrossRefGoogle Scholar
  187. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, Regan CM, Walsh DM, Sabatini BL, Selkoe DJ (2008) Amyloid-beta protein dimers isolated directly from Alzheimer’s brains impair synaptic plasticity and memory. Nat Med 14(8):837–842PubMedCrossRefGoogle Scholar
  188. Shimizu K, Muraoka Y, Hirose S, Tomii K, Noguchi T (2007) Predicting mostly disordered proteins by using structure-unknown protein data. BMC Bioinformatics 8:78PubMedCrossRefGoogle Scholar
  189. Sidransky E (2006) Heterozygosity for a Mendelian disorder as a risk factor for complex disease. Clin Genet 70:275–282PubMedCrossRefGoogle Scholar
  190. Spector A, Woods B, Orrell M (2008) Cognitive stimulation for the treatment of Alzheimer’s disease. Expert Rev Neurother 8:751–757PubMedCrossRefGoogle Scholar
  191. Stefani M, Dobson CM (2003) Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J Mol Med 81:678–699PubMedCrossRefGoogle Scholar
  192. Stephan A, Laroche S, Davis S (2001) Generation of aggregated beta-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits. J Neurosci 21:5703–5714PubMedGoogle Scholar
  193. Sulzer D (2007) Multiple hit hypotheses for dopamine neuron loss in Parkinson’s disease. Trends Neurosci 30:244–250PubMedCrossRefGoogle Scholar
  194. Swaab DF (1992) How to prevent the retiring brain from degenerating. Clin Neurol Neurosurg 94(Suppl):S150–S152PubMedCrossRefGoogle Scholar
  195. Takeuchi H, Jin S, Suzuki H, Doi Y, Liang J, Kawanokuchi J, Mizuno T, Sawada M, Suzumura A (2008) Blockade of microglial glutamate release protects against ischemic brain injury. Exp Neurol PMID:18775425Google Scholar
  196. Tamo W, Imaizumi T, Tanji K, Yoshida H, Mori F, Yoshimoto M, Takahashi H, Fukuda I, Wakabayashi K, Satoh K (2002) Expression of alpha-synuclein, the precursor of non-amyloid beta component of Alzheimer’s disease amyloid, in human cerebral blood vessels. Neurosci Lett 21326(1):5–8CrossRefGoogle Scholar
  197. Tanzi E (1893) I fatti e le induzioni nell’odierna isologia del sistema nervosa. Riv Sper Freniatr Med Leg 19:419–472Google Scholar
  198. Taylor JS, Gaze RM (1985) The effects of the fibre environment on the paths taken by regenerating optic nerve fibres in Xenopus. J Embryol Exp Morphol 89:383–401PubMedGoogle Scholar
  199. Tofaris GK, Spillantini MG (2007) Physiological and pathological properties of alpha-synuclein. Cell Mol Life 64:2194–2201CrossRefGoogle Scholar
  200. Torres GE (2006) The dopamine transporter proteome. J Neurochem 97(1):3–10PubMedCrossRefGoogle Scholar
  201. Torricelli C, Capurro E, Santucci A, Paffetti A, D’Ambrosio C, Scaloni A, Maioli E, Pacini A (2004) Multiple plasma proteins control atrial natriuretic peptide (ANP) aggregation. J Mol Endocrinol 33:335–341PubMedCrossRefGoogle Scholar
  202. Tucker BA, Rahimtula M, Mearow KM (2005) Integrin activation and neurotrophin signaling cooperate to enhance neurite outgrowth in sensory neurons. J Comp Neurol 486:267–280PubMedCrossRefGoogle Scholar
  203. Turrigiano GG (1999) Homeostatic plasticity in neuronal networks: the more things change, the more they stay the same. Trends Neurosci 22:221–227PubMedCrossRefGoogle Scholar
  204. Unger JW (1998) Glial reaction in aging and Alzheimer’s disease. Microsc Res Tech 43:24–28PubMedCrossRefGoogle Scholar
  205. Uversky VN (2007) Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation. J Neurochem 103:17–37PubMedGoogle Scholar
  206. Vanden Berghe T, Declercq W, Vandenabeele P (2007) NADPH oxidases: new players in TNF-induced necrotic cell death. Mol Cell 26:769–771CrossRefGoogle Scholar
  207. Vermeulen RJ, Jongenelen CAM, Langeveld CH, Wolters E, Stoof JC, Drukarch B (1994) Dopamine D1 receptor agonists display a different intrinsic activity in rat, monkey and human astrocytes. Eur J Pharmacol 269:121–125PubMedCrossRefGoogle Scholar
  208. Volles MJ, Lansbury PT Jr (2002) Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson’s disease-linked mutations and occurs by a pore-like mechanism. Biochemistry 41:4595–4602PubMedCrossRefGoogle Scholar
  209. Von Bernhardi R (2007) Glial cell dysregulation: a new perspective on Alzheimer disease. Neurotox Res 12:215–232Google Scholar
  210. Vullo A, Bortolami O, Pollastri G, Tosatto SC (2006) Spritz: a server for the prediction of intrinsically disordered regions in protein sequences using kernel machines. Nucleic Acids Res 34:W164–W168PubMedCrossRefGoogle Scholar
  211. Wade C, Tavris C (2007) Invitation to psychology. Prentice Hall, Upper Saddle RiverGoogle Scholar
  212. Wang H, Yuan G, Prabhakar NR, Boswell M, Katz DM (2006) Secretion of brain-derived neurotrophic factor from PC12 cells in response to oxidative stress requires autocrine dopamine signalling. J Neurochem 96:694–705PubMedCrossRefGoogle Scholar
  213. Waxman EA, Lynch DR (2005) N-methyl-d-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease. Neuroscientist 11:37–49PubMedCrossRefGoogle Scholar
  214. Williams SR, Wozny C, Mitchell SJ (2007) The back and forth of dendritic plasticity. Neuron 56:947–953PubMedCrossRefGoogle Scholar
  215. Willuhn I, Steiner H (2008) Motor-skill learning in a novel running-wheel task is dependent on D1 dopamine receptors in the striatum. Neuroscience 153:249–258PubMedCrossRefGoogle Scholar
  216. Winklhofer KF, Tatzelt J, Haass C (2008) The two faces of protein misfolding: gain- and loss-of-function in neurodegenerative diseases. EMBO J 27:336–349PubMedCrossRefGoogle Scholar
  217. Wright PE, Dyson HJ (1999) Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. J Mol Biol 293:321–331PubMedCrossRefGoogle Scholar
  218. Yamada K, Nabeshima T (2003) Brain-derived neurotrophic factor/TrkB signaling in memory processes. J Pharmacol Sci 91:267–270PubMedCrossRefGoogle Scholar
  219. Yamaguchi H, Nakazato Y, Hirai S, Shoji M, Harigaya Y (1989) Electron micrograph of diffuse plaques. Initial stage of senile plaque formation in the Alzheimer brain. Am J Pathol 135(4):593–597PubMedGoogle Scholar
  220. Yankner BA, Lu T, Loerch P (2008) The aging brain. Annu Rev Pathol 3:41–46PubMedCrossRefGoogle Scholar
  221. Yao WD, Spealman RD, Zhang J (2008) Dopaminergic signaling in dendritic spines. Biochem Pharmacol 75(11):2055–2069PubMedCrossRefGoogle Scholar
  222. Zacchigna S, Lambrechts D, Carmeliet P (2008) Neurovascular signalling defects in neurodegeneration. Nat Rev Neurosci 9:169–181PubMedCrossRefGoogle Scholar
  223. Ziemińska E, Stafiej A, Łazarewicz JW (2003) Role of group I metabotropic glutamate receptors and NMDA receptors in homocysteine-evoked acute neurodegeneration of cultured cerebellar granule neurones. Neurochem Int 43:481–492PubMedCrossRefGoogle Scholar
  224. Zou S, Li L, Pei L, Vukusic B, Van Tol HH, Lee FJ, Wan Q, Liu F (2005) Protein–protein coupling/uncoupling enables dopamine D2 receptor regulation of AMPA receptor-mediated excitotoxicity. J Neurosci 25:4385–4395PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • L. F. Agnati
    • 1
    • 2
  • G. Leo
    • 1
    • 2
  • S. Genedani
    • 1
    • 2
  • L. Piron
    • 2
  • A. Rivera
    • 5
  • D. Guidolin
    • 4
  • K. Fuxe
    • 3
  1. 1.Department of BioMedical SciencesUniversity of ModenaModenaItaly
  2. 2.IRCCS San Camillo, Lido VeneziaVeneziaItaly
  3. 3.Department of NeuroscienceKarolinska InstitutetStockholmSweden
  4. 4.Department of Human Anatomy and PhysiologyUniversity of PadovaPaduaItaly
  5. 5.Department of Cell Biology, School of ScienceUniversity of MálagaMálagaSpain

Personalised recommendations